We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Enzyme Patent Dispute Settled For $8.2M

Law360 (February 20, 2007, 12:00 AM EST) -- Danish biotech company Danisco A/S will pay rival Novozymes A/S over $8.2 million to settle an ongoing patent infringement suit after a district court judge ruled Monday that Danisco willfully infringed Novozymes’ patent for the enzyme Spezyme Ethyl.

After two bench trials, U.S. District Court Judge Kent A. Jordan said because Danisco subsidiary Genencor International Inc. willfully infringed Novozymes’ patent, the plaintiff was entitled to double damages and reasonable attorneys’ fees.

Judge Jordan of the U.S. District Court for the District of Delaware also permanently enjoined...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.